Myasthenia gravis: Frequently asked questions

被引：13

作者：

Morren, John A. ^{[1
,2
]}

Li, Yuebing ^{[2
,3
,4
]}

机构：

[1] Cleveland Clin, Neurol Inst, Neuromuscular Ctr, Cleveland, OH USA

[2] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Cleveland, OH USA

[3] Cleveland Clin, Neurol Inst, Neuromuscular Ctr, Dept Neurol, Cleveland, OH USA

[4] Cleveland Clin, Neurol Inst, S90,9500 Euclid Ave, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2023年 / 90卷 / 02期

关键词：

INTERNATIONAL CONSENSUS GUIDANCE; QUALITY-OF-LIFE; DOUBLE-BLIND; THYMECTOMY; PREDNISONE; MANAGEMENT;

D O I：

10.3949/ccjm.90a.22017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Myasthenia gravis is a disorder of neuromuscular junction transmission, the result of antibodies against the post synaptic aspect of the neuromuscular junction. Its clinical hallmark is fatigable weakness of skeletal muscles, which tends to vary in location and severity among patients. It is treated with pyridostigmine, immunotherapy, and thymectomy. Treatment is often individualized according to disease severity, antibody status, comorbidities, and other factors. This review uses a question-and-answer format to provide up-to-date, high-yield, clinically relevant information on myasthenia gravis.

引用

页码：103 / 113

页数：11

共 57 条

[1] Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients [J].

Bachmann, Kai ;

Burkhardt, Doreen ;

Schreiter, Inken ;

Kaifi, Jussuf ;

Busch, Christoph ;

Thayssen, Gunther ;

Izbicki, Jakob R. ;

Strate, Tim .

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2008, 22 (11) :2470-2477

[2]

Beloor Suresh A, 2021, STATPEARLS

[3] A systematic review of population based epidemiological studies in Myasthenia Gravis [J].

Carr, Aisling S. ;

Cardwell, Chris R. ;

McCarron, Peter O. ;

McConville, John .

BMC NEUROLOGY, 2010, 10

[4]

CHRISTENSEN PB, 1995, ACTA NEUROL SCAND, V91, P192

[5] Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations [J].

Dresser, Laura ;

Wlodarski, Richard ;

Rezania, Kourosh ;

Soliven, Betty .

JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)

[6] Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum [J].

Dubey, Divyanshu ;

David, William S. ;

Reynolds, Kerry L. ;

Chute, Donald F. ;

Clement, Nathan F. ;

Cohen, Justine V. ;

Lawrence, Donald P. ;

Mooradian, Meghan J. ;

Sullivan, Ryan J. ;

Guidon, Amanda C. .

ANNALS OF NEUROLOGY, 2020, 87 (05) :659-669

[7] STUDY OF LONG-TERM ANTICHOLINESTERASE THERAPY - EFFECTS ON NEUROMUSCULAR-TRANSMISSION AND ON MOTOR ENDPLATE FINE-STRUCTURE [J].

ENGEL, AG ;

LAMBERT, EH ;

SANTA, T .

NEUROLOGY, 1973, 23 (12) :1273-1281

[8] Treatment of Myasthenia Gravis [J].

Farmakidis, Constantine ;

Pasnoor, Mamatha ;

Dimachkie, Mazen M. ;

Barohn, Richard J. .

NEUROLOGIC CLINICS, 2018, 36 (02) :311-+

[9] Juvenile Myasthenia Gravis: A Paediatric Perspective [J].

Finnis, Maria F. ;

Jayawant, Sandeep .

AUTOIMMUNE DISEASES, 2011, 2011

[10] THE COURSE OF MYASTHENIA-GRAVIS AND THERAPIES AFFECTING OUTCOME [J].

GROB, D ;

ARSURA, EL ;

BRUNNER, NG ;

NAMBA, T .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 :472-499

← 1 2 3 4 5 6 →